ConvaTec Group (LON:CTEC) Cut to Add at Peel Hunt
Peel Hunt cut shares of ConvaTec Group (LON:CTEC) to an add rating in a research report sent to investors on Friday, Stock Target Advisor reports. Peel Hunt currently has GBX 225 ($2.77) target price on the stock, up from their prior target price of GBX 220 ($2.71).
CTEC has been the subject of several other reports. Credit Suisse Group raised their target price on ConvaTec Group from GBX 175 ($2.15) to GBX 180 ($2.22) and gave the stock an underperform rating in a research report on Friday, May 1st. CSFB raised their target price on ConvaTec Group from GBX 175 ($2.15) to GBX 180 ($2.22) and gave the stock an underperform rating in a research report on Friday, May 1st. Royal Bank of Canada raised ConvaTec Group to an outperform rating and raised their target price for the stock from GBX 178 ($2.19) to GBX 245 ($3.02) in a research report on Wednesday, June 10th. UBS Group increased their price objective on ConvaTec Group from GBX 235 ($2.89) to GBX 245 ($3.02) and gave the stock a buy rating in a research note on Friday, May 1st. Finally, Barclays increased their price objective on ConvaTec Group from GBX 182 ($2.24) to GBX 190 ($2.34) and gave the stock an equal weight rating in a research note on Monday, May 18th. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company’s stock. ConvaTec Group has a consensus rating of Hold and a consensus price target of GBX 213.50 ($2.63).
Shares of CTEC stock opened at GBX 195.80 ($2.41) on Friday. The stock has a market cap of $3.96 billion and a P/E ratio of 396.00. ConvaTec Group has a one year low of GBX 140.40 ($1.73) and a one year high of GBX 225.80 ($2.78). The stock has a fifty day moving average price of GBX 206.44 and a 200 day moving average price of GBX 198.01. The company has a debt-to-equity ratio of 100.87, a current ratio of 2.44 and a quick ratio of 1.64.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
See Also: What is the FTSE 100 index?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.